Valiant Organics Q2 FY27 Standalone Net Profit at Rs. 1,715.05 Lakhs
RESULTS
▲ Positive Development
LOW RISK
📅 Filed on BSE: 05 Nov 2026, 07:35 PM IST · BSE ID: d82fe204-5aca-4054-84b0-a67835112f0f
View Original BSE Filing (PDF)
💡
In Simple Terms
Valiant Organics' board approved its financial results, showing a quarterly net profit of Rs. 1,715.05 Lakhs.
🤖 AI Summary
- Valiant Organics Ltd. reported standalone Net Profit of Rs. 1,715.05 Lakhs for Q2 FY27.
- Revenue from Operations for the quarter ended September 30, 2026, was Rs. 30,421.76 Lakhs.
- Half-year standalone Net Profit reached Rs. 3,897.32 Lakhs for the period ended September 30, 2026.
- Total Expenses for Q2 FY27 stood at Rs. 28,068.81 Lakhs.
- The Board of Directors approved these unaudited results on November 5, 2026.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Standalone Revenue from Operations (Q2 FY27)
30,421.76 Lakhs
93.51%
Standalone Net Profit (Q2 FY27)
1,715.05 Lakhs
206.46%
Standalone Revenue from Operations (H1 FY27)
53,575.61 Lakhs
48.16%
Standalone Net Profit (H1 FY27)
3,897.32 Lakhs
195.82%
Basic EPS (Q2 FY27)
6.12 Rs.
206.00%
🏢 How This Affects the Company
The company reported an increase in revenue from operations for the quarter and half-year periods, indicating expanded business activity compared to the prior year.
Net Profit for Q2 FY27 was Rs. 1,715.05 Lakhs, with half-year net profit at Rs. 3,897.32 Lakhs, contributing to the company's accumulated earnings.
The disclosure of a new reportable segment, 'Pharma Business', alongside 'Speciality Chemicals', reflects a change in internal operational reporting structure from Q4 FY26.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this financial results announcement.
👤
Who Is Affected
All shareholders are affected by the company's financial performance, as reflected in the Q2 FY27 standalone net profit of Rs. 1,715.05 Lakhs and half-year net profit of Rs. 3,897.32 Lakhs.
🔍
Management Signal
The management's approval and disclosure of the financial results, including the new Pharma Business segment, signals a commitment to transparent reporting and strategic business segmentation.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List - track these upcoming events
Q3 FY27 financial results — monitor continued revenue and profit trends.
Updates on the 'Pharma Business' segment's performance and contribution.
Details on capital expenditure related to segment expansion.
LOW RISK
The filing is a routine financial results disclosure with positive year-on-year growth, indicating no immediate new risks.
💡 Investor Takeaway
Valiant Organics reported Q2 FY27 standalone Net Profit of Rs. 1,715.05 Lakhs, a substantial increase from Rs. 559.62 Lakhs in Q2 FY26. Revenue from Operations grew to Rs. 30,421.76 Lakhs from Rs. 15,720.69 Lakhs year-on-year. Half-year Net Profit for FY27 was Rs. 3,897.32 Lakhs, up from Rs. 1,317.47 Lakhs in H1 FY26.
⚖️ Strengths & Concerns
✅ Positives
- Standalone Revenue from Operations for Q2 FY27 increased to Rs. 30,421.76 Lakhs from Rs. 15,720.69 Lakhs in Q2 FY26.
- Half-year standalone Net Profit for FY27 reached Rs. 3,897.32 Lakhs, compared to Rs. 1,317.47 Lakhs in the same period of FY26.
⚠️ Concerns
- Profit before tax for Q2 FY27 was Rs. 2,463.61 Lakhs, a sequential decrease from Rs. 2,891.70 Lakhs in Q1 FY27.
- Changes in inventories of Finished Goods, WIP & Stock-In-Trade moved from a negative (reduction) of (1,678.97) Lakhs in Q1 FY27 to a positive (increase) of 610.49 Lakhs in Q2 FY27, indicating inventory build-up.
📅 Company Track Record
Valiant Organics previously published Q1 FY27 results on August 14, 2026. Prior to that, the board was scheduled to approve Q4 FY26 results on May 16, 2026. The company informed BSE about the current Q2 FY27 results board meeting on October 31, 2026. In FY26, the company recognised Rs. 572.08 Lakhs as exceptional income from a fire insurance claim settlement.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Valiant Organics' standalone Net Profit for the quarter ended September 30, 2026?
Valiant Organics reported a standalone Net Profit of Rs. 1,715.05 Lakhs for the quarter ended September 30, 2026 (Q2 FY27).
What was Valiant Organics' Revenue from Operations for Q2 FY27?
The Revenue from Operations for Valiant Organics in Q2 FY27 was Rs. 30,421.76 Lakhs.
How did Valiant Organics' standalone Net Profit compare year-on-year for Q2?
Standalone Net Profit for Q2 FY27 was Rs. 1,715.05 Lakhs, an increase from Rs. 559.62 Lakhs reported in the corresponding Q2 FY26.
What was Valiant Organics' half-year standalone Net Profit for the period ended September 30, 2026?
For the half-year ended September 30, 2026 (H1 FY27), Valiant Organics recorded a standalone Net Profit of Rs. 3,897.32 Lakhs.
When did Valiant Organics' Board of Directors approve these Q2 FY27 financial results?
The Board of Directors of Valiant Organics Ltd. approved the unaudited financial results for Q2 FY27 on November 5, 2026.
Questions based on this BSE filing only. For information purposes.